Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
N Engl J Med
    September 2022
  1. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    >> Share

  2. COLIZZO FP, Shroff SG, High FA, Chen YB, et al
    Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy.
    N Engl J Med. 2022;387:1124-1134.
    >> Share

  3. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    >> Share

  4. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    >> Share

  5. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    >> Share

  6. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    >> Share

    August 2022
  7. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    >> Share

  8. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    >> Share

    July 2022
  9. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    >> Share

    June 2022
  10. KUTER DJ
    Rilzabrutinib in Immune Thrombocytopenia. Reply.
    N Engl J Med. 2022;386:2538.
    >> Share

  11. MURAKAMI J, Senoo Y, Tanimoto T
    Rilzabrutinib in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:2537-2538.
    >> Share

  12. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    >> Share

  13. HUANG YM, Lin PH
    IgG4-Related Ophthalmic Disease.
    N Engl J Med. 2022;386:2315.
    >> Share

  14. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    >> Share

    April 2022
  15. WARE J, Hovorka R
    Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2022;386:1482-1483.
    >> Share

  16. RING BL
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    >> Share

  17. MURATA Y, Takita M, Kami M
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    >> Share

  18. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
    Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:1421-1431.
    >> Share

    March 2022
  19. SPERLING MA, Laffel LM
    Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    N Engl J Med. 2022;386:1155-1164.
    >> Share

  20. COSTENBADER KH
    A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
    N Engl J Med. 2022;386:1085-1086.
    >> Share

  21. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
    Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
    N Engl J Med. 2022;386:1034-1045.
    >> Share

    January 2022
  22. YONG GY, Lim AL
    Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:374.
    >> Share

  23. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
    Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:209-219.
    >> Share

  24. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
    Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
    N Engl J Med. 2022;386:173-180.
    >> Share

  25. PAVORD S, Lester W, Hunt BJ
    Clinical Features of VITT. Reply.
    N Engl J Med. 2022;386.
    >> Share

  26. CHITI A
    Clinical Features of VITT.
    N Engl J Med. 2022;386.
    >> Share

    December 2021
  27. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    >> Share

  28. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    >> Share

  29. BRADBURY CA, Hill Q, Greenwood R
    Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
    N Engl J Med. 2021;385:2201-2202.
    >> Share

  30. VAN DIJK WEM, Schutgens REG
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2201.
    >> Share

  31. GHANIMA W, Zaja F, Michel M
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200-2201.
    >> Share

  32. CHEN S, Dong C, Wei JC
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200.
    >> Share

    November 2021
  33. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
    Treatment of Diabetes - To Pump or Not to Pump.
    N Engl J Med. 2021;385:2092-2095.
    >> Share

  34. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
    Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
    N Engl J Med. 2021;385:1974-1980.
    >> Share

  35. BJORNSTAD P, Drews K, Zeitler PS
    Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
    N Engl J Med. 2021;385:2016.
    >> Share

  36. NELSON RG, Hanson RL, Knowler WC
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2015.
    >> Share

  37. YANG W, Wang C
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2014-2015.
    >> Share

  38. MOUGIAKAKOS D, Kronke G, Schett G
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2021;385:e67.
    >> Share

  39. KONIG MF, Paul S
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:e67.
    >> Share

  40. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    >> Share

    October 2021
  41. BERENTSEN S, Barcellini W
    Autoimmune Hemolytic Anemias.
    N Engl J Med. 2021;385:1407-1419.
    >> Share

    September 2021
  42. WERTH VP, Joly P, Chen DM
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    N Engl J Med. 2021;385:1056.
    >> Share

  43. HOPKINS ZH, Wu BC, Nousari CH
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    N Engl J Med. 2021;385:1055-1056.
    >> Share

  44. BOLTON-MAGGS PHB, George JN
    Immune Thrombocytopenia Treatment.
    N Engl J Med. 2021;385:948-950.
    >> Share

  45. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
    N Engl J Med. 2021;385:885-895.
    >> Share

    August 2021
  46. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    >> Share

  47. GOYAL RK
    Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
    N Engl J Med. 2021;385:576.
    >> Share

  48. AKTURK HK, Shah VN
    Gastric Emptying Abnormalities in Diabetes Mellitus.
    N Engl J Med. 2021;385:575-576.
    >> Share

  49. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
    CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:567-569.
    >> Share

    July 2021
  50. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
    Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
    N Engl J Med. 2021;385:451-460.
    >> Share

  51. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
    A Periodic Problem.
    N Engl J Med. 2021;385:e17.
    >> Share

  52. AVELAR RODRIGUEZ D, Orkin J
    An Icteric Tongue.
    N Engl J Med. 2021;385:e16.
    >> Share

  53. MORAN-THOMAS A
    One Hundred Years of Insulin for Some.
    N Engl J Med. 2021;385:293-295.
    >> Share

  54. GOGLIN SE, Margaretten ME
    Malar Rash.
    N Engl J Med. 2021;385:164.
    >> Share

  55. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    >> Share

    June 2021
  56. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    >> Share

  57. SEEKER P, Osswald S
    Tongue Discoloration.
    N Engl J Med. 2021;384:e102.
    >> Share

  58. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
    Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    N Engl J Med. 2021;384:2295-2305.
    >> Share

    May 2021
  59. JAYNE DRW, Merkel PA, Bekker P
    Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2021;384:e81.
    >> Share

  60. MATSUO Y, Miyabe Y
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    >> Share

  61. CHANDWAR K
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    >> Share

  62. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    >> Share

  63. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    >> Share

  64. FRALICK M, Sarma S
    Thyrotoxic Periodic Paralysis.
    N Engl J Med. 2021;384:e71.
    >> Share

  65. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    >> Share

    April 2021
  66. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
    Case 13-2021: A Newborn Girl with a Neck Mass.
    N Engl J Med. 2021;384:1647-1655.
    >> Share

  67. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    >> Share

  68. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    >> Share

  69. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    >> Share

  70. ZONOZI R, Niles JL
    Sunken Nose.
    N Engl J Med. 2021;384:e52.
    >> Share

    March 2021
  71. BUTLER PC
    Supplying Insulin while Evading Immunity.
    N Engl J Med. 2021;384:967-969.
    >> Share

    February 2021
  72. WARRINGTON KJ
    Avacopan - Time to Replace Glucocorticoids?
    N Engl J Med. 2021;384:664-665.
    >> Share

  73. JAYNE DRW, Merkel PA, Schall TJ, Bekker P, et al
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:599-609.
    >> Share

  74. GOVERMAN JM
    Regulatory T Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:578-580.
    >> Share

  75. WU C, Dai R
    Central Retinal Artery and Vein Occlusion.
    N Engl J Med. 2021;384:e9.
    >> Share

    January 2021
  76. ZAMVIL SS, Hauser SL
    Antigen Presentation by B Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:378-381.
    >> Share

  77. FURIE R, Rovin BH, Roth DA
    Belimumab in Lupus Nephritis. Reply.
    N Engl J Med. 2021;384:188.
    >> Share

  78. SCHONERMARCK U, Kemmner S, Fischereder M
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187-188.
    >> Share

  79. ROJAS-RIVERA J, Ortiz A, Carriazo S
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187.
    >> Share

  80. ANDERSON MS, Chaimowitz NS, Forbes LR
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply.
    N Engl J Med. 2021;384:93-94.
    >> Share

  81. JOHNSON MB, Hattersley AT, Patel KA
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition.
    N Engl J Med. 2021;384:93.
    >> Share

    December 2020
  82. LEVY-LAHAD E, King MC
    Hiding in Plain Sight - Somatic Mutation in Human Disease.
    N Engl J Med. 2020;383:2680-2682.
    >> Share

  83. BECK DB, Ferrada MA, Sikora KA, Ombrello AK, et al
    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2020;383:2628-2638.
    >> Share

  84. BRETON MD, Beck RW, Wadwa RP
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2020;383:2484.
    >> Share

  85. FERNANDES N
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:2484.
    >> Share

  86. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    >> Share

    November 2020
  87. ADANG L, Goldbach-Mansky R, Vanderver A
    JAK Inhibition in the Aicardi-Goutieres Syndrome. Reply.
    N Engl J Med. 2020;383:2191-2193.
    >> Share

  88. NEVEN B, Al Adba B, Hully M, Desguerre I, et al
    JAK Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:2190-2191.
    >> Share

  89. ACCILI D
    Whither Type 1 Diabetes?
    N Engl J Med. 2020;383:2078-2079.
    >> Share

  90. QUATTRIN T, Haller MJ, Steck AK, Felner EI, et al
    Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    N Engl J Med. 2020;383:2007-2017.
    >> Share

  91. CAPLAN DN, Rapalino O, Karaa A, Rosovsky RP, et al
    Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation.
    N Engl J Med. 2020;383:1974-1983.
    >> Share

  92. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    >> Share

    October 2020
  93. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    >> Share

  94. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    >> Share

  95. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    >> Share

  96. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    >> Share

  97. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    >> Share

  98. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    >> Share

  99. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    >> Share

  100. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    >> Share

  101. GO JR, Abu Saleh OM
    Vancomycin-Induced Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;383:1577.
    >> Share

  102. MIZUSHIMA N, Levine B
    Autophagy in Human Diseases.
    N Engl J Med. 2020;383:1564-1576.
    >> Share

  103. OH JY
    Autoimmune Keratitis after Atezolizumab Treatment.
    N Engl J Med. 2020;383:1468.
    >> Share

  104. CHAIMOWITZ NS, Ebenezer SJ, Hanson IC, Anderson M, et al
    STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.
    N Engl J Med. 2020;383:1494-1496.
    >> Share

    September 2020
  105. WANG G, Li H, Yang X, Guo T, et al
    Guillain-Barre Syndrome Associated with JEV Infection.
    N Engl J Med. 2020;383:1188-1190.
    >> Share

  106. WARD M, Tektonidou MG
    Belimumab as Add-on Therapy in Lupus Nephritis.
    N Engl J Med. 2020;383:1184-1185.
    >> Share

  107. OSTENDORF L, Burns M, Durek P, Heinz GA, et al
    Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2020;383:1149-1155.
    >> Share

  108. FURIE R, Rovin BH, Houssiau F, Malvar A, et al
    Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    N Engl J Med. 2020;383:1117-1128.
    >> Share

  109. BLUESTONE JA, Anderson M
    Tolerance in the Age of Immunotherapy.
    N Engl J Med. 2020;383:1156-1166.
    >> Share

  110. TRAPNELL BC, Inoue Y, Bonella F, Morgan C, et al
    Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2020 Sep 7. doi: 10.1056/NEJMoa1913590.
    >> Share

  111. VANDERVER A, Adang L, Gavazzi F, McDonald K, et al
    Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:986-989.
    >> Share

    August 2020
  112. BRETON MD, Kanapka LG, Beck RW, Ekhlaspour L, et al
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:836-845.
    >> Share

  113. MUELLER AA, Vaidya A, Tarter LL, Klein JP, et al
    Caught in a Flare.
    N Engl J Med. 2020;383:e48.
    >> Share

  114. HAUSER SL, Bar-Or A, Cohen JA, Comi G, et al
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    N Engl J Med. 2020;383:546-557.
    >> Share

    July 2020
  115. WU K
    Uncertain Trust.
    N Engl J Med. 2020;383:204-205.
    >> Share

  116. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    >> Share

  117. GAY E
    Blame.
    N Engl J Med. 2020;383:9.
    >> Share

    June 2020
  118. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    >> Share

  119. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    >> Share

  120. DORIA A, Galecki AT, Spino C, Pop-Busui R, et al
    Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    N Engl J Med. 2020;382:2493-2503.
    >> Share

  121. VICO-ALONSO C, Palencia-Perez S
    Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;382:2248.
    >> Share

    May 2020
  122. WALSH M, Merkel PA, Jayne DRW
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2020;382:2169.
    >> Share

  123. ESPOSITO P, Cipriani L, Viazzi F
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168-2169.
    >> Share

  124. SEXTON DJ
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168.
    >> Share

  125. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    >> Share

  126. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    >> Share

  127. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    >> Share

  128. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    >> Share

    April 2020
  129. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    >> Share

  130. MORAND EF, Furie RA
    Anifrolumab in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2020;382:1666.
    >> Share

  131. PUTMAN M
    Anifrolumab in Systemic Lupus Erythematosus.
    N Engl J Med. 2020;382:1665-1666.
    >> Share

  132. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    >> Share

  133. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    >> Share

  134. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016